Search results for "Type I"

showing 10 items of 966 documents

Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex

2004

medicine.medical_specialtyAngiotensin receptorAngioedemaC1 inhibitor deficiencybusiness.industryFemale sexGeneral Medicinemedicine.diseaseEndocrinologyInternal medicineHereditary angioedemamedicineHereditary Angioedema Type IIImedicine.symptombusinessThe American Journal of Medicine
researchProduct

Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal

2006

Endothelial NO synthase (eNOS) is the predominant enzyme responsible for vascular NO synthesis. A functional eNOS transfers electrons from NADPH to its heme center, where L-arginine is oxidized to L-citrulline and NO. Common conditions predisposing to atherosclerosis, such as hypertension, hypercholesterolemia, diabetes mellitus and smoking, are associated with enhanced production of reactive oxygen species (ROS) and reduced amounts of bioactive NO in the vessel wall. NADPH oxidases represent major sources of ROS in cardiovascular pathophysiology. NADPH oxidase-derived superoxide avidly interacts with eNOS-derived NO to form peroxynitrite (ONOO(-)), which oxidizes the essential NOS cofactor…

medicine.medical_specialtyAntioxidantNitric Oxide Synthase Type IIImedicine.medical_treatmentClinical BiochemistryNitric Oxidemedicine.disease_causeBiochemistrychemistry.chemical_compoundEnosInternal medicinemedicineAnimalsHumansVascular DiseasesEnzyme InhibitorsMolecular BiologyHemeJanus Kinaseschemistry.chemical_classificationReactive oxygen speciesNADPH oxidasebiologySuperoxidebiology.organism_classificationOxygenEndocrinologychemistrybiology.proteinPeroxynitriteOxidative stressBiological Chemistry
researchProduct

Pentaerithrityl tetranitrate improves angiotensin II induced vascular dysfunction via induction of heme oxygenase-1

2010

The organic nitrate pentaerythritol tetranitrate is devoid of nitrate tolerance, which has been attributed to the induction of the antioxidant enzyme heme oxygenase (HO)-1. With the present study, we tested whether chronic treatment with pentaerythritol tetranitrate can improve angiotensin II–induced vascular oxidative stress and dysfunction. In contrast to isosorbide-5 mononitrate (75 mg/kg per day for 7 days), treatment with pentaerythritol tetranitrate (15 mg/kg per day for 7 days) improved the impaired endothelial and smooth muscle function and normalized vascular and cardiac reactive oxygen species production (mitochondria, NADPH oxidase activity, and uncoupled endothelial NO synthase)…

medicine.medical_specialtyAntioxidantNitric Oxide Synthase Type IIImedicine.medical_treatmentVasodilator AgentsBlotting WesternFluorescent Antibody TechniquePentaerythritol tetranitratemedicine.disease_causePentaerythritolArticlechemistry.chemical_compoundInternal medicineRats Inbred SHRInternal MedicinemedicineAnimalsPentaerythritol TetranitrateEndothelial dysfunctionchemistry.chemical_classificationReactive oxygen speciesAnalysis of VarianceAngiotensin IImedicine.diseaseAngiotensin IIMitochondriaRatsHeme oxygenaseOxidative StressEndocrinologychemistryHeminEndothelium VascularReactive Oxygen SpeciesOxidative stressHeme Oxygenase-1
researchProduct

Effects of polymorphisms in endothelial nitric oxide synthase and folate metabolizing genes on the concentration of serum nitrate, folate, and plasma…

2015

Abstract Objectives A number of studies have explored the effects of dietary nitrate on human health. Nitrate in the blood can be recycled to nitric oxide, which is an essential mediator involved in many important biochemical mechanisms. Nitric oxide is also formed in the body from l -arginine by nitric oxide synthase. The aim of this study was to investigate whether genetic polymorphisms in endothelial nitric oxide synthase (eNOS) and genes involved in folate metabolism affect the concentration of serum nitrate, serum folate, and plasma total homocysteine in healthy individuals after folic acid supplementation. Methods In a randomized double-blind, crossover study, participants were given …

medicine.medical_specialtyArginineGenotyping TechniquesNitric Oxide Synthase Type IIIEndocrinology Diabetes and MetabolismArgininePolymorphism Single NucleotideNitric oxidechemistry.chemical_compoundFolic AcidNitrateDouble-Blind MethodGene FrequencyEnosInternal medicinemedicineDietary CarbohydratesHumansHomocysteineNutrition and DieteticsCross-Over StudiesNitratesbiologyDose-Response Relationship DrugDecreased Concentrationbiology.organism_classificationCrossover studyDietary FatsHealthy VolunteersVitamin B 6Nitric oxide synthaseEndocrinologychemistryBiochemistryMethylenetetrahydrofolate reductaseDietary Supplementsbiology.proteinDietary ProteinsNutrition (Burbank, Los Angeles County, Calif.)
researchProduct

Circadian rhythm in NO synthase I transcript expression and its photoperiodic regulation in the rat pineal gland.

2001

The photoneural regulation of nitric oxide synthase type I (NOS I) expression in the rat pineal was investigated using semiquantitative RT-PCR. NOS I transcript expression exhibited a daily rhythm with peak values during the night hours. The daily rhythm in NOS I transcript expression persisted under constant dark conditions and was abolished under constant light conditions. The extent of nocturnal NOS I expression was found to be dependent on the photoperiod. It was attenuated under 20 h light and 4 h dark (L:D 20:4) compared with 12 h light and 12 h dark (L:D 12:12). The present findings indicate that, in the rat pineal, NOS I transcript expression exhibits a true circadian rhythm. Furthe…

medicine.medical_specialtyArylamine N-AcetyltransferasePhotoperiodNitric Oxide Synthase Type IBiologyPineal GlandGene Expression Regulation EnzymologicRats Sprague-DawleyTranscription (biology)Internal medicineGene expressionmedicineAnimalsCircadian rhythmRNA MessengerMuridaephotoperiodismRegulation of gene expressionGeneral Neurosciencebiology.organism_classificationCircadian RhythmRatsNitric oxide synthaseEndocrinologybiology.proteinNitric Oxide SynthaseEndocrine glandNeuroreport
researchProduct

Relation of PvuII site polymorphism in the COL1A2 gene to the risk of fractures in prepubertal Finnish girls.

2003

Genetic susceptibility to fractures may be detectable in early childhood. We evaluated the associations between the polymorphic PvuII site of the COL1A2 gene and bone properties assessed by different modalities (dual-energy X-ray absorptiometry; peripheral quantitative computed tomography; gel coupling scanning quantitative ultrasonometry; ultrasound bone sonometry), bone turnover markers, and the occurrence of fractures in 244 prepubertal Finnish girls. Tanner stage and physical characteristics did not differ significantly among girls with different COL1A2 genotypes. The polymorphism was not significantly associated with different bone properties or any of the bone turnover markers when gi…

medicine.medical_specialtyBone densityPhysiologyOsteoporosisBiologyPolymorphism Single NucleotideCollagen Type IBone remodelingFractures BoneBone DensityRisk FactorsInternal medicineGenotypeGeneticsmedicineHumansGenetic Predisposition to DiseaseTibiaQuantitative computed tomographyChildDeoxyribonucleases Type II Site-SpecificFinlandRetrospective StudiesBone mineralBinding SitesPolymorphism Geneticmedicine.diagnostic_testPubertyAnthropometrymedicine.diseaseEndocrinologyFemaleBone RemodelingCollagenPhysiological genomics
researchProduct

Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women

2003

Objective: It is conceivable that, since menopause accelerates the continuous bone loss determined by age, a specific configuration of bone mass determinants during the first postmenopausal years occurs. Methods: To establish their value as indicators of bone mass in women with recent natural menopause, we assessed relationships between bone mineral density (BMD) and age, menopausal age, body mass index (BMI), PTH, sex steroid hormones (estradiol and testosterone), and several markers of bone turnover in urine (N-telopeptide and calcium/creatinine ratio) or serum (osteocalcin (OC), total alkaline phosphatase (ALP), total and ionic calcium (iCa), phosphate (P) and magnesium (Mg)) for a group…

medicine.medical_specialtyBone diseaseBone densityOsteocalcinOsteoporosisParathyroid hormoneCollagen Type IGeneral Biochemistry Genetics and Molecular BiologyBody Mass IndexPhosphatesBone remodelingBone DensityReference ValuesInternal medicinemedicineHumansMagnesiumTestosteroneOsteoporosis PostmenopausalFemoral neckBone mineralEstradiolbusiness.industryObstetrics and GynecologyMiddle AgedAlkaline Phosphatasemedicine.diseaseMenopauseEndocrinologymedicine.anatomical_structureParathyroid HormoneCreatinineCalciumFemaleCollagenPeptidesbusinessBiomarkersMaturitas
researchProduct

Characteristics of patients with mucopolysaccharidosis type II who have received a bone marrow transplant: Data from the Hunter Outcome Survey

2019

Mucopolysaccharidosis type II (MPS II Hunter syndrome) is a rare, life-limiting, X-linked lysosomal storage disease. The Hunter Outcome Survey (HOS) is a Shire-sponsored, global, observational registry initiated in 2005 that collects real-world data on the natural history of MPS II and long-term treatment with enzyme replacement therapy (ERT) with idursulfase. Patients receiving other forms of pharmacological ERT are excluded from HOS but individuals who have received a bone marrow transplant (BMT) may be enrolled. This analysis examined the characteristics of 36 male patients in HOS from Europe and North America who had received a BMT (March 2018 data). In total, 22 patients (61.1%) were E…

medicine.medical_specialtyBone marrow transplantIdursulfasebusiness.industryEndocrinology Diabetes and MetabolismHunter syndromeEnzyme replacement therapymedicine.diseaseBiochemistryNatural historyEndocrinologyGraft-versus-host diseaseRespiratory failureInternal medicineGeneticsmedicineMucopolysaccharidosis type IIbusinessMolecular Biologymedicine.drugMolecular Genetics and Metabolism
researchProduct

Role of GSH in the modulation of NOS-2 expression in the weaned mammary gland

2005

GSH delivery to the lactating mammary gland is essential for the maintenance of lactation as its decrease leads to apoptosis and involution of the mammary gland. In fact, it has already been demonstrated that some of the changes in gene expression found in the lactating mammary gland after forced weaning are reproduced in rats treated with buthionine sulphoximine to deplete GSH levels. An oligonucleotide microarray experiment would give us a better knowledge of the mRNA expression patterns during lactation and after weaning and the possible functions of GSH in the modulation of these events.

medicine.medical_specialtyButhionine SulphoximineMammary glandNitric Oxide Synthase Type IIBiologyNitric OxideBiochemistrychemistry.chemical_compoundMammary Glands AnimalInternal medicineLactationGene expressionmedicineAnimalsLactationWeaningInvolution (medicine)Gene Expression ProfilingGlutathioneGlutathioneIsoenzymesEndocrinologymedicine.anatomical_structureGene Expression RegulationchemistryApoptosisFemaleBiochemical Society Transactions
researchProduct

Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I

2000

This study was conducted to evaluate the influence of proinsulin C-peptide on erythrocyte Na(+),K(+)-ATPase and endothelial nitric oxide synthase activities in patients with type I diabetes. In a randomized double-blind study design, ten patients with type I diabetes received intravenous infusions of either human C-peptide or physiological saline on two different occasions. C-peptide was infused at a rate of 3 pmol.min(-1).kg(-1) for 60 min, and thereafter at 10 pmol.min(-1).kg(-1) for 60 min. At baseline and after 60 and 120 min, laser Doppler flow (LDF) was measured following acetylcholine iontophoresis or mild thermal stimulation (44 degrees C), and venous blood samples were collected to…

medicine.medical_specialtyC-peptideArbitrary unitNitric Oxide Synthase Type IIIVenous bloodGeneral MedicineNitric oxidechemistry.chemical_compoundRed blood cellEndocrinologymedicine.anatomical_structurechemistryInternal medicinemedicineAcetylcholinemedicine.drugProinsulinClinical Science
researchProduct